Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.

Rao, Ravi D; Flynn, Patrick J; Sloan, Jeff A; Wong, Gilbert Y; Novotny, Paul; Johnson, David B; Gross, Howard M; Renno, Samer I; Nashawaty, Mohammed; Loprinzi, Charles L

Rao, Ravi D; Flynn, Patrick J; Sloan, Jeff A; Wong, Gilbert Y; Novotny, Paul; Johnson, David B; Gross, Howard M; Renno, Samer I; Nashawaty, Mohammed; Loprinzi, Charles L.

Affiliation

Rao RD; Department of Medical Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.

Cancer ; 112(12): 2802-8, 2008 Jun 15.

Article in En | MEDLINE | ID: mdl-18428211

Subject(s)

Antineoplastic Agents/adverse effects; Peripheral Nervous System Diseases/drug therapy; Triazines/therapeutic use; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Evaluation; Female; Humans; Lamotrigine; Male; Middle Aged; Peripheral Nervous System Diseases/chemically induced; Placebos

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazines / Peripheral Nervous System Diseases / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2008 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google